mRNA RSV Vaccines (e.g., Abrysvo, Arexvy)

Type: vaccine

Status: FDA Approved, EMA Approved

Developer: Pfizer, GSK

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026